BATF2 Antibody
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in defense response to protozoan; myeloid dendritic cell differentiation; and regulation of transcription by RNA polymerase II. Predicted to be part of chromatin. Predicted to be active in nucleus. This antibody recognizes a transcription factor involved in differentiation of CD8+ thymic dendritic cells. BATF2 has been implicated in breast cancer, malignant glioma and metastatis melanoma progression.
Product Specifications
CAS Number
9007-83-4
Specifications
ELISA (Order BSA-free format for coating), Flow cytometry: 1-2ug/million cells, Immunohistochemistry (FFPE) : 1-2 µg/mL for 30 minutes at RT
UniProt
Q8N1L9
Host
Mouse
Reactivity
Human
Immunogen
A recombinant partial protein (within amino acids 5-140) from the human protein was used as the immunogen for the BATF2 antibody.
Clonality
Monoclonal
Isotype
IgG2b κ
Clone
PCRP-BATF2-2B9
Applications
ELISA, FACS, IHC-P
Purity
Protein A/G affinity
Format
Purified
Buffer
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Reconstitution
Aliquot the BATF2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitations
This BATF2 antibody is available for research use only.
Storage Conditions
Aliquot the BATF2 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Formulation
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05% sodium azide
Applications Notes
Optimal dilution of the BATF2 antibody should be determined by the researcher.
Location
Nucleus
Image Legend
Documents
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items